High-Throughput Gene Expression Profiles to Define Drug Similarity and Predict Compound Activity
2017 Acknowledgment of Reviewers
Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119
Machine Learning Enables Live Label-Free Phenotypic Screening in Three Dimensions
Know When You Don't Know: A Robust Deep Learning Approach in the Presence of Unknown Phenotypes
Integration of Antibody Array Technology into Drug Discovery and Development
A Phenotypic High-Content Screening Assay to Identify Regulators of Membrane Protein Localization
Drug Repurposing Patent Applications April–June 2016
Society of Biomolecular Imaging and Informatics Special Issue
Closantel Suppresses Angiogenesis and Cancer Growth in Zebrafish Models
Interference Potential of Tannins and Chlorophylls in Zebrafish Phenotypic-Based Assays
Research in Rare Disease: From Genomics to Proteomics
Society of Biomolecular Imaging and Informatics Special Issue, October 2016
Interview with Kaylene Simpson, PhD
Drug Repurposing Patent Applications July–September 2016
Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria
Antihypertensive, Amlodipine Besilate Inhibits Growth and Biofilm of Human Fungal Pathogen Candida
Transcriptional Characterization of Compounds: Lessons Learned from the Public LINCS Data
An Automated Miniaturized Method to Perform and Analyze Antimicrobial Drug Synergy Assays
Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture
Interview with Farid Khan, PhD
Benefits of Strategic Small-Scale Targeted Screening
Drug Repurposing Patent Applications October–December 2015
SBI2 High Content 2016, 3rd Annual Conference, September 12th-14th
Interview with Dr. Nandu Gattu